Cargando…
High efficacy of chlorfenapyr-based net Interceptor(®) G2 against pyrethroid-resistant malaria vectors from Cameroon
BACKGROUND: The increasing reports of resistance to pyrethroid insecticides associated with reduced efficacy of pyrethroid-only interventions highlight the urgency of introducing new non-pyrethroid-only control tools. Here, we investigated the performance of piperonyl-butoxide (PBO)-pyrethroid [Perm...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463949/ https://www.ncbi.nlm.nih.gov/pubmed/37641108 http://dx.doi.org/10.1186/s40249-023-01132-w |
_version_ | 1785098352663199744 |
---|---|
author | Tchouakui, Magellan Thiomela, Riccado F. Nchoutpouen, Elysee Menze, Benjamin D. Ndo, Cyrille Achu, Dorothy Tabue, Raymond N. Njiokou, Flobert Joel, Ateba Wondji, Charles S. |
author_facet | Tchouakui, Magellan Thiomela, Riccado F. Nchoutpouen, Elysee Menze, Benjamin D. Ndo, Cyrille Achu, Dorothy Tabue, Raymond N. Njiokou, Flobert Joel, Ateba Wondji, Charles S. |
author_sort | Tchouakui, Magellan |
collection | PubMed |
description | BACKGROUND: The increasing reports of resistance to pyrethroid insecticides associated with reduced efficacy of pyrethroid-only interventions highlight the urgency of introducing new non-pyrethroid-only control tools. Here, we investigated the performance of piperonyl-butoxide (PBO)-pyrethroid [Permanet 3.0 (P3.0)] and dual active ingredients (AI) nets [Interceptor G2 (IG2): containing pyrethroids and chlorfenapyr and Royal Guard (RG): containing pyrethroids and pyriproxyfen] compared to pyrethroid-only net Royal Sentry (RS) against pyrethroid-resistant malaria vectors in Cameroon. METHODS: The efficacy of these tools was firstly evaluated on Anopheles gambiae s.l. and Anopheles funestus s.l. from Gounougou, Mibellon, Mangoum, Nkolondom, and Elende using cone/tunnel assays. In addition, experimental hut trials (EHT) were performed to evaluate the performance of unwashed and 20 times washed nets in semi-field conditions. Furthermore, pyrethroid-resistant markers were genotyped in dead vs alive, blood-fed vs unfed mosquitoes after exposure to the nets to evaluate the impact of these markers on net performance. The XLSTAT software was used to calculate the various entomological outcomes and the Chi-square test was used to compare the efficacy of various nets. The odds ratio and Fisher exact test were then used to establish the statistical significance of any association between insecticide resistance markers and bed net efficacy. RESULTS: Interceptor G2 was the most effective net against wild pyrethroid-resistant An. funestus followed by Permanet 3.0. In EHT, this net induced up to 87.8% mortality [95% confidence interval (CI): 83.5–92.1%) and 55.6% (95% CI: 48.5–62.7%) after 20 washes whilst unwashed pyrethroid-only net (Royal Sentry) killed just 18.2% (95% CI: 13.4–22.9%) of host-seeking An. funestus. The unwashed Permanet 3.0 killed up to 53.8% (95% CI: 44.3–63.4%) of field-resistant mosquitoes and 47.2% (95% CI: 37.7–56.7%) when washed 20 times, and the Royal Guard 13.2% (95% CI: 9.0–17.3%) for unwashed net and 8.5% (95% CI: 5.7–11.4%) for the 20 washed net. Interceptor G2, Permanet 3.0, and Royal Guard provided better personal protection (blood-feeding inhibition 66.2%, 77.8%, and 92.8%, respectively) compared to pyrethroid-only net Royal Sentry (8.4%). Interestingly, a negative association was found between kdrw and the chlorfenapyr-based net Interceptor G2 (χ(2) = 138; P < 0.0001) with homozygote-resistant mosquitoes predominantly found in the dead ones. CONCLUSIONS: The high mortality recorded with Interceptor G2 against pyrethroid-resistant malaria vectors in this study provides first semi-field evidence of high efficacy against these major malaria vectors in Cameroon encouraging the implementation of this novel net for malaria control in the country. However, the performance of this net should be established in other locations and on other major malaria vectors before implementation at a large scale. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-023-01132-w. |
format | Online Article Text |
id | pubmed-10463949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104639492023-08-30 High efficacy of chlorfenapyr-based net Interceptor(®) G2 against pyrethroid-resistant malaria vectors from Cameroon Tchouakui, Magellan Thiomela, Riccado F. Nchoutpouen, Elysee Menze, Benjamin D. Ndo, Cyrille Achu, Dorothy Tabue, Raymond N. Njiokou, Flobert Joel, Ateba Wondji, Charles S. Infect Dis Poverty Research Article BACKGROUND: The increasing reports of resistance to pyrethroid insecticides associated with reduced efficacy of pyrethroid-only interventions highlight the urgency of introducing new non-pyrethroid-only control tools. Here, we investigated the performance of piperonyl-butoxide (PBO)-pyrethroid [Permanet 3.0 (P3.0)] and dual active ingredients (AI) nets [Interceptor G2 (IG2): containing pyrethroids and chlorfenapyr and Royal Guard (RG): containing pyrethroids and pyriproxyfen] compared to pyrethroid-only net Royal Sentry (RS) against pyrethroid-resistant malaria vectors in Cameroon. METHODS: The efficacy of these tools was firstly evaluated on Anopheles gambiae s.l. and Anopheles funestus s.l. from Gounougou, Mibellon, Mangoum, Nkolondom, and Elende using cone/tunnel assays. In addition, experimental hut trials (EHT) were performed to evaluate the performance of unwashed and 20 times washed nets in semi-field conditions. Furthermore, pyrethroid-resistant markers were genotyped in dead vs alive, blood-fed vs unfed mosquitoes after exposure to the nets to evaluate the impact of these markers on net performance. The XLSTAT software was used to calculate the various entomological outcomes and the Chi-square test was used to compare the efficacy of various nets. The odds ratio and Fisher exact test were then used to establish the statistical significance of any association between insecticide resistance markers and bed net efficacy. RESULTS: Interceptor G2 was the most effective net against wild pyrethroid-resistant An. funestus followed by Permanet 3.0. In EHT, this net induced up to 87.8% mortality [95% confidence interval (CI): 83.5–92.1%) and 55.6% (95% CI: 48.5–62.7%) after 20 washes whilst unwashed pyrethroid-only net (Royal Sentry) killed just 18.2% (95% CI: 13.4–22.9%) of host-seeking An. funestus. The unwashed Permanet 3.0 killed up to 53.8% (95% CI: 44.3–63.4%) of field-resistant mosquitoes and 47.2% (95% CI: 37.7–56.7%) when washed 20 times, and the Royal Guard 13.2% (95% CI: 9.0–17.3%) for unwashed net and 8.5% (95% CI: 5.7–11.4%) for the 20 washed net. Interceptor G2, Permanet 3.0, and Royal Guard provided better personal protection (blood-feeding inhibition 66.2%, 77.8%, and 92.8%, respectively) compared to pyrethroid-only net Royal Sentry (8.4%). Interestingly, a negative association was found between kdrw and the chlorfenapyr-based net Interceptor G2 (χ(2) = 138; P < 0.0001) with homozygote-resistant mosquitoes predominantly found in the dead ones. CONCLUSIONS: The high mortality recorded with Interceptor G2 against pyrethroid-resistant malaria vectors in this study provides first semi-field evidence of high efficacy against these major malaria vectors in Cameroon encouraging the implementation of this novel net for malaria control in the country. However, the performance of this net should be established in other locations and on other major malaria vectors before implementation at a large scale. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-023-01132-w. BioMed Central 2023-08-29 /pmc/articles/PMC10463949/ /pubmed/37641108 http://dx.doi.org/10.1186/s40249-023-01132-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Tchouakui, Magellan Thiomela, Riccado F. Nchoutpouen, Elysee Menze, Benjamin D. Ndo, Cyrille Achu, Dorothy Tabue, Raymond N. Njiokou, Flobert Joel, Ateba Wondji, Charles S. High efficacy of chlorfenapyr-based net Interceptor(®) G2 against pyrethroid-resistant malaria vectors from Cameroon |
title | High efficacy of chlorfenapyr-based net Interceptor(®) G2 against pyrethroid-resistant malaria vectors from Cameroon |
title_full | High efficacy of chlorfenapyr-based net Interceptor(®) G2 against pyrethroid-resistant malaria vectors from Cameroon |
title_fullStr | High efficacy of chlorfenapyr-based net Interceptor(®) G2 against pyrethroid-resistant malaria vectors from Cameroon |
title_full_unstemmed | High efficacy of chlorfenapyr-based net Interceptor(®) G2 against pyrethroid-resistant malaria vectors from Cameroon |
title_short | High efficacy of chlorfenapyr-based net Interceptor(®) G2 against pyrethroid-resistant malaria vectors from Cameroon |
title_sort | high efficacy of chlorfenapyr-based net interceptor(®) g2 against pyrethroid-resistant malaria vectors from cameroon |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463949/ https://www.ncbi.nlm.nih.gov/pubmed/37641108 http://dx.doi.org/10.1186/s40249-023-01132-w |
work_keys_str_mv | AT tchouakuimagellan highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT thiomelariccadof highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT nchoutpouenelysee highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT menzebenjamind highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT ndocyrille highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT achudorothy highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT tabueraymondn highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT njiokouflobert highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT joelateba highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon AT wondjicharless highefficacyofchlorfenapyrbasednetinterceptorg2againstpyrethroidresistantmalariavectorsfromcameroon |